By Dr Narjess Ayati

Book Chapters

Hofman MS; Ayati N, 2023, 'Case Study #7: PSMA-617', in Radiopharmaceutical Therapy, pp. 369 - 386, http://dx.doi.org/10.1007/978-3-031-39005-0_18

Journal articles

Buteau JP; Moon D; Fahey MT; Roberts MJ; Ayati N; Papa N; Murphy DG; Kasivisvanathan V; Dhillon HM; Du YT; Dundee P; Foudoulis J; Hennes D; Hutton AC; Idiare J; Jack G; Kamath S; Lee SN; Lee SF; Lee ST; Leslie S; Levy SM; Link E; Mitchell C; Morigi JJ; Nguyen A; Olphert J; Patel MI; Pattison DA; Pearce A; Perera M; Thanigasalam R; Thomson A; Yaxley J; Thompson J; Hofman MS; Emmett L; Adams L; Akhurst TJ; Alghazo O; Alipour R; Ayati N; Balino A; Baring A; Berlangieri S; Bills M; Boehm E; Boktor R; Bollampally N; Burt C; Buteau JP; Callegari E; Cardin A; Chan Y; Chen DC; Chen T; Cullen K; De Abreu Lourenco R; Devitt K; Dhiantravan N; Dhillon HM; Di Iulio J; Du YT; Eapen R; Emmett L; Ende D; Fahey MT; Fernando D; Francis RJ; Frydenberg M; Guduguntla G; Ghosh G; Grummet JP; Harley S; Hennes D; Hickey A; Ho B; Hong E; Hutton AC; Jack G; Jewell KE; John N; Kamath S; Kashyap RK; Kasivisvanathan V; Kesuma S; Khan U; Kong G; Kovaleva N; Lau E; Lawrentschuk N; Lee D; Lee J; Lee SF; Lee ST; Lee SN, 2026, 'Effect of [68Ga]Ga-PSMA-11 PET-CT in the diagnosis of prostate cancer in men with equivocal or clinically high-risk non-suspicious findings on multiparametric MRI (PRIMARY2): a multicentre, non-inferiority, phase 3, randomised controlled trial', Lancet Oncology, 27, pp. 839 - 848, http://dx.doi.org/10.1016/S1470-2045(26)00120-8

Kashyap R; Buteau JP; Papa N; Ayati N; Eifer M; Betech-Antar V; Akhurst T; Alipour R; Kong G; Saghebi J; Ravi Kumar AS; Cardin A; Sandhu S; Tran B; Azad AA; Murphy DG; Hofman MS, 2026, 'Prognostic Value of Restaging [18F]FDG PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [177Lu]Lu-PSMA-617 Therapy.', J Nucl Med, http://dx.doi.org/10.2967/jnumed.126.272531

Khan S; Papa N; Kneebone A; Eade T; Ayati N; Nguyen A; Wong K; Chen J; Ho B; Idiare J; Sidhom G; Roberts MJ; Thompson J; Sharma S; Weir S; Devitt K; Kooner R; Lieng H; Rasiah K; Olphert J; de Leon J; Hruby G; Stricker P; Emmett L, 2026, 'Prospective Comparison of 64Copper [64Cu]SAR-bisPSMA vs 68Gallium[68Ga] PSMA-11 PET/CT for Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy (Co-PSMA Trial)', European Urology, 89, pp. 512 - 520, http://dx.doi.org/10.1016/j.eururo.2026.03.001

Ayati N; Papa N; Crumbaker M; Subramaniam S; Joshua AM; Alipour R; Iravani A; Askari E; Khan S; Yadav S; Eiber M; Weickhardt A; Lee ST; Ng S; Francis RJ; Goh JC; Pattison DA; Tan TH; Kirkwood ID; Nguyen A; Hofman MS; Sandhu S; Hioki T; van Oorschodt JCJ; Devitt K; Willowson K; Sharma S; Stancu A; Chauvie S; Wilson P; Martin AJ; Thomas H; Stockler MR; Davis ID; Emmett L, 2026, '177Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate Cancer', Radiology, 319, http://dx.doi.org/10.1148/radiol.252672

Karpinski MJ; Civan C; Rauscher I; Güven O; Eiber M; Hoberück S; Miederer M; Bundschuh RA; Hölscher T; Calais J; Theus L; Nguyen AT; Scholtissek H; Lapa C; Di Giorgio A; Farolfi A; Ufton D; Drzezga A; Kunikowska J; Pełka K; Evangelista L; Bauman G; Alçın G; Beintner-Skawran S; Rohani MFM; Miksch J; Hüsing A; Kesch C; Herrmann K; Stuschke M; Umutlu L; Gafita A; Hofman MS; Hope TA; Goffin K; Kind F; Pizzuto DA; Soeterik TFW; Kömek H; Emmett L; Vondrak A; Pinter T; Lanfranchi F; Bauckneht M; Unterrainer LM; Holzgreve A; Bjartell A; Trägårdh E; Rasul S; Miszczyk M; Bögemann M; Rodriguez SantAnna Jauregui N; Schäfers M; Rahbar K; Hadaschik BA; Fendler WP; Hekimsoy T; Coban Ö; Thomas C; Krause M; Platzek I; Kopka K; Kimura K; Pfob CH; Rapa M; Bianchi L; Stepień-Dziekan J; Giełdowski K; Fasulo V; Alionte C; Arslan E; Maurer A; Nakamoto R; Tuncel M; Fernandes Nunes R; Zacho HD; Santangelo A; İnce B; Ahmadi Bidakhvidi N; Annunziata S; Van Melick HHE; Güzel Y; Ayati N; Passoni J; Sambuceti G; Sheikh GT; Siegmund SC; Hacker M; Shariat SF, 2026, 'New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort study', Lancet Oncology, 27, pp. 480 - 490, http://dx.doi.org/10.1016/S1470-2045(26)00016-1

Emmett L; Swiha M; Papa N; Subramaniam S; Crumbaker M; Joshua AM; Nguyen A; Weickhardt A; Lee ST; Ng S; Francis RJ; Goh JC; Pattison DA; Pathmanandavel S; Hope T; Ayati N; Hofman MS; Sandhu S; Niu C; Martin AJ; Thomas H; Stockler MR; Davis ID, 2026, 'Predictive value of early PSMA upregulation for the response to enzalutamide ± 177Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer: substudy of the randomized, phase 2 ENZA-p trial', Nature Cancer, 7, pp. 622 - 630, http://dx.doi.org/10.1038/s43018-026-01140-3

Karpinski MJ; Hoberück S; Fendler WP; Civan C; Bundschuh RA; Thomas C; Bjartell A; Trägårdh E; Soeterik TFW; Evangelista L; Vondrak A; Rasul S; Forner L; Giorgio AD; Scholtissek H; Miksch J; Holzgreve A; Lanfranchi F; Rahbar K; Hofman MS; Rauscher I; Güven O; Eiber M; Ayati N; Umutlu L; Herrmann K; Hadaschik B; Emmett L, 2026, 'Association Between the PRIMARY Score at Staging Prostate-specific Membrane Antigen Positron Emission Tomography and Overall Survival Among Patients with Newly Diagnosed Prostate Cancer: Findings from the International, Multicenter PROMISE Registry', European Urology, 89, pp. 123 - 127, http://dx.doi.org/10.1016/j.eururo.2025.10.013

Emmett L; Papa N; Sartor O; Morris MJ; Subramaniam S; Crumbaker M; Ayati N; Chen J; Herrmann K; Gafita A; Swiha M; Joshua AM; Weickhardt A; Lee ST; Ng S; Francis RJ; Goh JC; Pattison DA; Ho B; Khan S; Tan TH; Bills M; Nguyen A; Thein T; Sidhom G; Wong K; Martin AJ; Hofman MS; Sandhu S; Thomas H; Stockler MR; Davis ID, 2026, 'Prognostic Value of Interim PSMA-PET Total Tumor Volume for Overall Survival Within ENZA-p, A Randomized Phase 2 Trial of Enzalutamide Versus Enzalutamide Plus [177Lu] Lu-PSMA-617 (ANZUP1901)', European Urology, http://dx.doi.org/10.1016/j.eururo.2026.03.026

Emmett L; Papa N; Ayati N; Nguyen A; Wong K; Chen J; Ho B; Idiare J; Sidhom G; Eade T; Roberts M; Thompson J; Sharma S; Weir S; Devitt K; Kooner R; Lieng H; Rasiah K; Olphert J; de Leon J; Hruby G; Stricker P; Kneebone A; Khan S, 2026, 'A0750 Prospective comparison of 64Copper [64Cu]SAR-bis-PSMA vs. 68Ga PSMA-11 PET CT for prostate cancer detection in patients with biochemical recurrence after radical prostatectomy (Co-PSMA trial)', European Urology, 89, pp. S1 - S2, http://dx.doi.org/10.1016/s0302-2838(26)00798-0

Karpinski M; Hoberück S; Fendler W; Civan C; Bundschuh RA; Thomas C; Bjartell A; Soeterik T; Evangelista L; Vondrak A; Rasul S; Forner L; Di Giorgio A; Scholtissek H; Miksch J; Holzgreve A; Lanfranchi F; Rahbar K; Hofman M; Rauscher I; Güven O; Eiber M; Ayati N; Umutlu L; Herrmann K; Hadaschik B; Emmett L, 2026, 'Assoziation zwischen PRIMARY-Score und Gesamtüberleben bei der Stadieneinteilung mittels PSMA-PET bei Patienten mit neu diagnostiziertem Prostatakrebs: Ergebnisse des internationalen, multizentrischen PROMISE-Registers', Nuklearmedizin - NuclearMedicine, 65, pp. 103 - 103, http://dx.doi.org/10.1055/s-0046-1818182

Shamshirgaran A; Samadi MH; Saeed M; Harsini S; Sahafi P; Divband G; Mohammadi G; Ayati N; Sadeghi R; Rizzo A; Treglia G; Askari E, 2025, 'Fifty Shades of PSMA-Avid Rib Lesions: A Comprehensive Review', Cancers, 17, http://dx.doi.org/10.3390/cancers17213404

Emmett L; Papa N; Subramaniam S; Crumbaker M; Nguyen A; Joshua AM; Sandhu S; Weickhardt A; Lee ST; Ng S; Francis RJ; Goh JC; Pattison DA; Tan TH; Kirkwood ID; Ayati N; Niu C; Hofman MS; Martin AJ; Thomas H; Davis ID; Stockler MR, 2025, 'Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant prostate cancer in ENZA-p (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trial', Lancet Oncology, 26, pp. 1168 - 1177, http://dx.doi.org/10.1016/S1470-2045(25)00339-0

Emmett L; Zheng A; Jin C; Papa N; Khan S; Ayati N; Susman T; Ngai K; Nelson A; Sharma S; Anand R; John N; Crumbaker M; Nguyen A; Herrmann K, 2025, ''One button push' fully automated PSMA PET quantification: Correlation with progression free and overall survival in patients undergoing [¹⁷⁷Lu] Lu PSMA therapy for metastatic castrate resistant prostate cancer.', JOURNAL OF CLINICAL ONCOLOGY, 43, http://dx.doi.org/10.1200/JCO.2025.43.16_suppl.5054

Sabahi Z; Papa N; Fendler WP; Nguyen A; Wong K; Ayati N; Ho B; Chen J; Cusick T; Burger I; Crumbaker M; Marx GM; Sharma S; Frydenberg M; Sandhu S; Davis ID; Stockler MR; Sweeney C; Joshua AM; Emmett L, 2025, 'Prognostic value of PSMA PET against CHAARTED criteria in an ENZAMET sub-cohort', JOURNAL OF CLINICAL ONCOLOGY, 43, http://dx.doi.org/10.1200/JCO.2025.43.16_suppl.5091

Sabahi Z; Nguyen A; Wong K; Li S; Papa N; Lim E; Dear RF; Menzies AM; Boyle F; Antill Y; Kiely BE; Forster BC; Mak C; Adams D; Pugliano L; Spillane A; Sharma S; Hickey A; Poole A; Agrawal S; Khan S; Ayati N; Emmett L, 2025, 'Diagnostic Potential of 68Ga-NeoB PET/CT with Estrogen Receptor– and Progesterone Receptor–Positive Breast Cancer Undergoing Staging or Restaging for Metastatic Disease', Journal of Nuclear Medicine, 66, pp. 700 - 706, http://dx.doi.org/10.2967/jnumed.124.268896

Swiha M; Pathmanandavel S; Papa N; Sabahi Z; Li S; Zheng A; Khan S; Ayers M; Sharma S; Crumbaker M; Nguyen A; Chan L; Ayati N; Emmett L, 2024, 'Comparison of Posttherapy 4- and 24-Hour [177Lu]Lu-PSMA SPECT/CT and Pretherapy PSMA PET/CT in Assessment of Disease in Men with Metastatic Castration-Resistant Prostate Cancer', Journal of Nuclear Medicine, 65, pp. 1939 - 1944, http://dx.doi.org/10.2967/jnumed.124.267606

Ayati N; McIntosh L; Buteau J; Alipour R; Pudis M; Daw N; Jackson P; Hofman MS, 2024, 'Comparison of quantitative whole body PET parameters on [68Ga]Ga-PSMA-11 PET/CT using ordered Subset Expectation Maximization (OSEM) vs. bayesian penalized likelihood (BPL) reconstruction algorithms in men with metastatic castration-resistant prostate cancer', Cancer Imaging, 24, http://dx.doi.org/10.1186/s40644-024-00702-x

Ayati N; Askari E; Fotouhi M; Soltanabadi M; Aghaee A; Roustaei H; Scott AM, 2024, 'Nuclear medicine imaging in non-seminomatous germ cell tumors: lessons learned from the past failures', Cancer Imaging, 24, http://dx.doi.org/10.1186/s40644-024-00794-5

Li S; Nguyen A; Counter W; John NC; De Leon J; Hruby G; Joshua AM; Stricker P; Crumbaker M; Ayati N; Chan L; Sabahi Z; Swiha M; Kneebone A; Wong K; Liu V; Sharma S; Agrawal S; Emmett LM, 2024, 'Utility of 64Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on 68Ga-PSMA-11 PET/CT', Journal of Nuclear Medicine, 65, pp. 1371 - 1375, http://dx.doi.org/10.2967/jnumed.124.267881

Buteau JP; Moon D; Fahey MT; Roberts MJ; Thompson J; Murphy DG; Papa N; Mitchell C; De Abreu Lourenco R; Dhillon HM; Kasivisvanathan V; Francis RJ; Stricker P; Agrawal S; O'Brien J; McVey A; Sharma G; Levy S; Ayati N; Nguyen A; Lee SF; Pattison DA; Sivaratnam D; Frydenberg M; Du Y; Titus J; Lee ST; Ischia J; Jack G; Hofman MS; Emmett L, 2024, 'Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer', European Urology Oncology, 7, pp. 544 - 552, http://dx.doi.org/10.1016/j.euo.2023.11.008

Swiha M; Papa N; Sabahi Z; Ayati N; John N; Pathmanandavel S; Crumbaker M; Li S; Agrawal S; Ayers M; Hickey A; Sharma S; Nguyen A; Emmett L, 2024, 'Development of a Visually Calculated SUVmean (HIT Score) on Screening PSMA PET/CT to Predict Treatment Response to 177Lu-PSMA Therapy: Comparison with Quantitative SUVmean and Patient Outcomes', Journal of Nuclear Medicine, 65, pp. 904 - 908, http://dx.doi.org/10.2967/jnumed.123.267014

Nesari Javan F; Askari E; Shafiei S; Roshanravan V; Aghaei A; Ayati N; Zakavi SR, 2024, 'The Prognostic Power of Preablation Stimulated Thyroglobulin in Children With Differentiated Thyroid Cancer', Endocrine Practice, 30, pp. 209 - 217, http://dx.doi.org/10.1016/j.eprac.2023.12.005

Swiha M; Ayati N; Oprea-Lager DE; Ceci F; Emmett L, 2024, 'How to Report PSMA PET', Seminars in Nuclear Medicine, 54, pp. 14 - 29, http://dx.doi.org/10.1053/j.semnuclmed.2023.07.007

Tolmeijer SH; Kwan EM; Ng SWS; Joshua A; Emmett L; Crumbaker M; Hamid AA; Anton A; Horvath LG; Chan J; Bressel M; Buteau JP; Dhiantravan N; Ayati N; Keerthikumar S; Goode D; Hicks R; Hofman MS; Wyatt AW; Sandhu SK, 2024, 'Circulating tumour DNA (ctDNA) measurements and PET-imaging to evaluate response in a phase Ib trial of metastatic castration-resistant prostate cancer (mCRPC) treated with Lutetium-177-PSMA-617 (LuPSMA) plus pembrolizumab (PRINCE)', ANNALS OF ONCOLOGY, 35, pp. S975 - S976, http://dx.doi.org/10.1016/j.annonc.2024.08.1697

Ayati N; Jamshidi-Araghi Z; Hoellwerth M; Schweighofer-Zwink G; Hitzl W; Koelblinger P; Pirich C; Beheshti M, 2023, 'Predictive value and accuracy of [18F]FDG PET/CT modified response criteria for checkpoint immunotherapy in patients with advanced melanoma', European Journal of Nuclear Medicine and Molecular Imaging, 50, pp. 2715 - 2726, http://dx.doi.org/10.1007/s00259-023-06247-8

Ayati N; Evans S; Rasoul Zakavi S; Gruenewald SM, 2023, 'Comparison between viral vector and mRNA based COVID-19 vaccination in prevalence and severity of regional immune reactions, and18 F-FDG PET/CT features', Asia Oceania Journal of Nuclear Medicine and Biology, 11, pp. 4 - 12, http://dx.doi.org/10.22038/AOJNMB.2022.63110.1443

Ayati N; Herrmann K; Fanti S; Murphy DG; Hofman MS, 2023, 'More Accurate Imaging Is Not Stage Migration: Time To Move from “Hubble” to “Webb” in Hormone-sensitive Prostate Cancer', European Urology, 83, pp. 6 - 9, http://dx.doi.org/10.1016/j.eururo.2022.10.005

Kiamanesh Z; Ayati N; Sadeghi R; Hawkes E; Lee ST; Scott AM, 2022, 'The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review', European Journal of Nuclear Medicine and Molecular Imaging, 49, pp. 4661 - 4676, http://dx.doi.org/10.1007/s00259-022-05918-2

Esmatinia M; Askari E; Aghaee A; Jahanpanah P; Ayati N; Shafiei S; Aryana K, 2022, 'Diagnostic value of [99mTc]Tc-HYNIC-TOC scintigraphy in the management of differentiated thyroid cancer with elevated thyroglobulin and negative radioiodine whole-body scan', Iranian Journal of Nuclear Medicine, 30, pp. 122 - 128

Javan FN; Ayati N; Sadri K; Ramezanzadeh E; Farahmandfar F; Beheshti S; Zakavi SR, 2022, 'Evaluation thyroglobulin level during suppressive therapy measured by ultrasensitive technique in the prediction of excellent response in patients with differentiated thyroid cancer', Iranian Journal of Nuclear Medicine, 30, pp. 109 - 114

Ayati N; Gruenewald S; Zakavi SR; Evans S, 2022, 'Comparison between Viral Vector and mRNA-Based COVID-19 Vaccination in Prevalence and Severity of Regional and Systemic Immune Reactions, and 18F-FDG PET/CT Features', World Journal of Nuclear Medicine, 21, pp. 085 - 098, http://dx.doi.org/10.1055/s-0042-1749222

Ayati N; Lee ST; Zakavi SR; Cheng M; Lau WFE; Parakh S; Pathmaraj K; Scott AM, 2021, 'Response Evaluation and Survival Prediction After PD-1 Immunotherapy in Patients with Non-Small Cell Lung Cancer: Comparison of Assessment Methods', Journal of Nuclear Medicine, 62, pp. 926 - 933, http://dx.doi.org/10.2967/jnumed.120.254508

Shafiei S; Sadrolodabaei M; Aghaei A; Ayati N; Namdar SZ; Hemati D; Zakavi SR, 2021, 'Longer time to reach excellent response to treatment in familial versus sporadic Non-medullary Thyroid Cancer (NMTC): A matched case-control study', International Journal of Endocrinology and Metabolism, 19, http://dx.doi.org/10.5812/IJEM.108781

rasoul ZaKaVi S; ayaTi N; Zare S; Ayati A; Sadri K; Fekri N; aBBaSi B; Shafiei S, 2021, 'Prognostic value and optimal threshold of first thyroglobulin in low/intermediate risk DTC', Quarterly Journal of Nuclear Medicine and Molecular Imaging, 65, pp. 64 - 71, http://dx.doi.org/10.23736/S1824-4785.19.03136-4

Ayati N; Sadeghi R; Kiamanesh Z; Lee ST; Zakavi SR; Scott AM, 2021, 'The value of 18F-FDG PET/CT for predicting or monitoring immunotherapy response in patients with metastatic melanoma: a systematic review and meta-analysis', European Journal of Nuclear Medicine and Molecular Imaging, 48, pp. 428 - 448, http://dx.doi.org/10.1007/s00259-020-04967-9

Ariamanesh S; Ayati N; Mazloum Khorasani Z; Mousavi Z; Kiavash V; Kiamanesh Z; Zakavi SR, 2020, 'Effect of Different 131I Dose Strategies for Treatment of Hyperthyroidism on Graves' Ophthalmopathy', Clinical Nuclear Medicine, 45, pp. 514 - 518, http://dx.doi.org/10.1097/RLU.0000000000003086

Kiamanesh Z; Ayati N; Alavi R; Gharedaghi M; Aryana K, 2019, 'Application of 99m Tc-UBI 29-41 scintigraphy in knee periprosthetic infection diagnosis', Nuklearmedizin Nuclearmedicine, 58, pp. 301 - 308, http://dx.doi.org/10.1055/a-0941-3317

Manafi-Farid R; Ayati N; Eftekhari M; Fallahi B; Masoumi F, 2019, 'A rare presentation of colorectal cancer with unusual progressive intramuscular and subcutaneous metastatic spread', Asia Oceania Journal of Nuclear Medicine and Biology, 7, pp. 89 - 94, http://dx.doi.org/10.22038/AOJNMB.2018.11934

Vatanchi A; Ayati N; Shafiei S; Ashourzade F; Purali L; Zakavi SR, 2019, 'Effects of radioiodine therapy on pregnancy and its complication in differentiated thyroid cancer comparing with their healthy sisters', Tehran University Medical Journal, 77, pp. 445 - 452

Shakeri S; Massoudi T; Ayati N; Davachi B; Aryana K, 2019, 'Pancake kidney: An unusual type of renal fusion anomaly found in 99mTc-DMSA renal scintigraphy', Iranian Journal of Nuclear Medicine, 27, pp. 60 - 62, http://dx.doi.org/10.18502/irjnm.v27i1.977

Ghayour-Mobarhan M; Ayati N; Sahebkar AH; Moohebati M; Ayati N; Elyasi S; Mohammadpour AH, 2018, 'Evaluation of serum Asymmetric Dimethyl Arginine concentrations in coronary artery disease patients without traditional cardiovascular risk factors', Acta Biomedica, 89, pp. 203 - 208, http://dx.doi.org/10.23750/abm.v89i2.5335

Ayati N; Lee ST; Zakavi R; Pathmaraj K; Al-Qatawna L; Poon A; Scott AM, 2018, 'Long-acting somatostatin analog therapy differentially alters 68 Ga-DOTATATE uptake in normal tissues compared with primary tumors and metastatic lesions', Journal of Nuclear Medicine, 59, pp. 223 - 227, http://dx.doi.org/10.2967/jnumed.117.192203

Ahmadzadehfar H; Aryana K; Pirayesh E; Farzanehfar S; Assadi M; Fallahi B; Shafiei B; Ayati N; Amoui M, 2018, 'The Iranian Society of Nuclear Medicine practical guideline on radioligand therapy in metastatic castration-resistant prostate cancer using 177Lu-PSMA', Iranian Journal of Nuclear Medicine, 26, pp. 2 - 8

Askari E; Sadeghi R; Ayati N, 2018, 'A case of popliteal artery entrapment syndrome: easy to miss in early angiographic phase of bone scan', European Journal of Medical Case Reports, 2, http://dx.doi.org/10.24911/ejmcr/173-1529346107

Ashrafpour R; Ayati N; Sadeghi R; Zare Namdar S; Ayati N; Ghahremani S; Zakavi SR, 2018, 'Comparison of Treatment Response Achieved by Tablet Splitting Versus Whole Tablet Administration of Levothyroxine in Patients with Thyroid Cancer.', Asia Ocean J Nucl Med Biol, 6, pp. 108 - 112, http://dx.doi.org/10.22038/aojnmb.2018.26793.1187

Banezhad F; Ayati N; Toosi FS; Boloursaz S; Zakavi SR, 2018, 'Extraosseous Accumulation of Technetium-99m-Methyl Diphosphonate (99mTc-MDP) in a Child with ALL: A Case Report.', Asia Ocean J Nucl Med Biol, 6, pp. 57 - 60, http://dx.doi.org/10.22038/aojnmb.2017.9679

Shafiei S; Ayati N; Sadra H; Kazemzadeh G; Namdar S; Attar B; Zakavi S, 2018, 'Is intermittent pneumatic compression (IPC) an appropriate method for increasing 99m Tc-MDP uptake in bone scan?', Pakistan Journal of Nuclear Medicine, pp. 3 - 7, http://dx.doi.org/10.24911/pjnmed.175-1529737505

Shakeri S; Zarehparvar Moghadam S; Sadeghi R; Ayati N, 2018, 'Sagliker Syndrome in a Patient with Secondary Hyperparathyroidism and Chronic Renal Insufficiency: A Case Report.', Asia Ocean J Nucl Med Biol, 6, pp. 167 - 170, http://dx.doi.org/10.22038/aojnmb.2018.10567

Aghaee A; Darmani P; Divband G; Zakavi S; Shafeie S; Zereaati A; Ayati N, 2018, 'The effect of radioactive iodine therapy on urine sterilization in patients with differentiated thyroid cancer', Pakistan Journal of Nuclear Medicine, pp. 27 - 30, http://dx.doi.org/10.24911/pjnmed.175-1532409254

Back to profile page